首页>
中文会议>第四届全国肿瘤介入治疗学术大会、肿瘤多学科综合治疗暨首届肿瘤靶向治疗东方国际论坛
>EGF-Receptor Antibody (Cetuximab) Plus Recombinant Human Endostatin (Endostar) is Active Treatment of Hepatic Metastases after Remnant Gastric Cancer Resection
EGF-Receptor Antibody (Cetuximab) Plus Recombinant Human Endostatin (Endostar) is Active Treatment of Hepatic Metastases after Remnant Gastric Cancer Resection